Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Agios soars after raising $106M in IPO

Agios Pharmaceuticals Inc. (NASDAQ:AGIO) jumped $13.28 (74%) to $31.28 in its first day of trading on Wednesday

Read the full 177 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE